Four N-(4-halophenyl)-4-oxo-4H-chromene-3-carboxamides (halo = F, Cl, Br and I), N-(4-fluorophenyl)-4-oxo-4H-chromene-3-carboxamide, C 16 H 10 FNO 3 , N-(4-chlorophenyl)-4-oxo-4H-chromene-3-carboxamide, C 16 H 10 ClNO 3 , N-(4-bromophenyl)-4-oxo-4H-chromene-3-carboxamide, C 16 H 10 BrNO 3 , N-(4-iodophenyl)-4-oxo-4H-chromene-3-carboxamide, C 16 H 10 INO 3 , have been structurally characterized. The molecules are essentially planar and each exhibits an anti conformation with respect to the C-N rotamer of the amide and a cis geometry with respect to the relative positions of the C arom -C arom bond of the chromone ring and the carbonyl group of the amide. The structures each exhibit an intramolecular hydrogen-bonding network comprising an N-HÁ Á ÁO hydrogen bond between the amide N atom and the O atom of the carbonyl group of the pyrone ring, forming an S(6) ring, and a weak C arom -HÁ Á ÁO interaction with the O atom of the carbonyl group of the amide as acceptor, which forms another S(6) ring. All four compounds have the same supramolecular structure, consisting of R 2 2 (13) rings that are propagated along the aaxis direction by unit translation. There is -stacking involving inversionrelated molecules in each structure.
Chemical context
Chromones are a group of natural and synthetic oxygen heterocyclic compounds having a high degree of chemical diversity that is frequently linked to a broad array of biological activities (Gaspar et al. 2014 ). Parkinson's disease (PD) is a degenerative disorder of the central nervous system with an aetiology not yet completely clarified. There is no cure for PD, but medications, surgery and multidisciplinary management can provide relief from the symptoms. PD seems to be associated with a decrease in central levels of dopamine triggered by oxidative stress. These processes, among other factors, are mediated by the isoform B of the monoamino oxidase (MAO-B). Hence, the search for novel agents that can selectively inhibit MAO-B is of paramount relevance. In this context, the decoration of chromone, a privileged structure for the discovery and development of new chemical entities (NCEs), have led to the preparation of chromone carboxamides and to promising outcomes since preliminary data indicate that chromone-3-carboxamides are selective MAO-B inhibitors Gaspar, Silva et al., 2011) .
Previous results showed that the carbonyl group of the chromone moiety and the amide function play an important role in the establishment of hydrogen interactions with the MAO-B active pocket. In addition, the presence of a phenyl substituent attached to the amide seems to play a pivotal role in the potency conveyed by the ligand (Helguera et al., 2013) .
In this context, some N-(4-halophenyl)-4-oxo-4H-chromene-3-carboxamides (1)-(4), shown in the scheme, have been synthesized and structurally characterized in order to rationalize the structural factors that may affect the selectivity and the potency of their inhibitory activities towards MAO-B. These structures are compared with N-(4-phenyl)-4-oxo-4H-chromene-2-carboxamide and N-(4-bromophenyl)-4-oxo-4H-chromene-2-carboxamide, compounds (5) and (6) Gomes et al., 2013) , which do not show inhibitory activities against human MAO-B.
Structural commentary
The structural analysis of (1)-(4) confirmed them to be N-(4-halophenyl)-4-oxo-4H-chromene-3-carboxamides with halosubstituents F (Fig. 1) , Cl (Fig. 2) , Br ( Fig. 3) and I (Fig. 4) , respectively, as depicted in the scheme. Figs. 1-4 show the displacement ellipsoid diagrams with the adopted labelling schemes. All compounds crystallize in the space group P1. Compounds (1) and (2) are isostructural, as are compounds (3) A view of the asymmetric unit of (1), showing the atom-numbering scheme. Displacement ellipsoids are drawn at the 80% probability level. Dashed lines indicate the intramolecular contacts. A view of the asymmetric unit of (2), showing the atom-numbering scheme. Displacement ellipsoids are drawn at the 80% probability level. Dashed lines indicate the intramolecular contacts.
Figure 3
A view of the asymmetric unit of (3), showing the atom-numbering scheme. Displacement ellipsoids are drawn at the 80% probability level. Dashed lines indicate the intramolecular contacts.
Figure 4
A view of the asymmetric unit of (4), showing the atom-numbering scheme. Displacement ellipsoids are drawn at the 80% probability level. Dashed lines indicate the intramolecular contacts.
The title compounds display similar structures, which are reflected in the molecular geometries and conformations; the values of the dihedral angles between the mean planes of the chromone ring and the exocyclic phenyl ring of the N-phenyl-4-oxo-4H-chromene-3-carboxamides are close to 2 in the case of the F, Cl pair [2.51 (3) and 1.95 (7) , respectively,] and close to 5
for the Br, I pair [4.90 (10) and 5.37 (10) , respectively]. In N-phenyl-4-oxo-4H-chromene-2-carboxamide (5) , the dihedral angle between the mean planes of the chromone ring and the phenyl ring is 6.57 and in N-(4-bromophenyl)-4-oxo-4H-chromene-2-carboxamide (6), the structural isomer of (3) , the dihedral angle between the mean planes of the chromone ring and the phenyl ring is 5.0 (2)
. Selected dihedral angles are given in Table 1 . In (1) and (2), the maximum deviations from the mean plane of the 10 atoms of the chromone ring plus the three carboxamide atoms O3, C31 and N3, are 0.1220 (8) and 0.1319 (17) Å , respectively, both for atom O3 (r.m.s. deviations of fitted atoms = 0.0519 and 0.0571 Å , respectively). In (3) and (4), the deviations of O3 from the mean plane defined above are 0.0384 (14) and 0.0342 (15) Å , respectively (r.m.s. deviations of fitted atoms = 0.0314 Å in both compounds). In the case of (3) and (4), atom C2 shows the greatest deviation from the mean plane having deviations of 0.0569 (18) and 0.0596 (18) Å , respectively. These values indicate that the carboxamide groups are practically planar with the chromone ring, particularly in the case of the Br and I chromone carboxamide derivatives. This planarity may be related to the internal hydrogen-bond pattern in those molecules, which thus defines the molecular conformations.
The conformational features herein established are probably most relevant for the extrapolation of the inhibitory MAO-B activities of chromone carboxamides as they are related to the intermolecular forces responsible for enzymeligand binding affinity. The data can explain the MAO-B selectivity found for chromone-3-carboxamides (1)-(4), as opposed to the lack of activity presented by chromone-2-carboxamides (5) and (6). As seen in the scheme, (1)-(4) are N-(phenyl)-4-oxo-4H-chromene-3-carboxamides while (5) and (6) are N-(phenyl)-4-oxo-4H-chromene-2-carboxamides. As can be seen in Fig. 5 , an anti conformation is adopted with respect to the C-N rotamer of the amide in all of the compounds. Nevertheless, due to the asymmetry of the chromone residue, the anti conformation can assume a cis (a) or trans (b) geometry with respect to the relative position of the carbonyl O atom of the carboxamide and the C2 arom -C3 arom bond of the chromone. Compounds (1)-(4) exhibit a cis relation between these bonds, as can be seen in the ellipsoid diagrams, Figs. 1-4. This molecular conformation permits the formation of two intramolecular hydrogen bonds, which generate a network that probably enhances their planarity. Details of the intramolecular hydrogen-bonding interactions are given in Tables 2 to 5 . Specifically for each molecule, there is an intramolecular N-HÁ Á ÁO hydrogen bond between the amide nitrogen and the oxygen atom of the carbonyl group, O4, of the chromone ring, forming an S(6) ring identified as ring C. In addition, the carbonyl oxygen of the amide, O3, acts as the acceptor for a weak interaction with an ortho hydrogen of the exocyclic phenyl ring, forming another S(6) ring, B. The corresponding trans structures (top right in Fig. 5 ) would probably only allow the formation of a weak hydrogenbonding interaction with an ortho hydrogen atom of the exocyclic phenyl ring. It is interesting to compare the internal hydrogen-bonding network presented by the title compounds with those of the analogous 4-oxo-N-(substituted phenyl)-4H- Hydrogen-bond geometry (Å , ) for (1). Symmetry codes: (i) x þ 1; y; z; (ii) x À 1; y; z.
Table 3
Hydrogen-bond geometry (Å , ) for (2). Symmetry codes: (i) x þ 1; y; z; (ii) x À 1; y; z.
Table 4
Hydrogen-bond geometry (Å , ) for (3). Symmetry codes: (i) x þ 1; y; z; (ii) x À 1; y; z.
Table 5
Hydrogen-bond geometry (Å , ) for (4). Symmetry codes: (i) x þ 1; y; z; (ii) x À 1; y; z.
chromene-2-carboxamides and , compounds (5) and (6). Previous studies concerning the structures of the chromone-2-carboxamides show that the majority have geometries similar to compound (5), e.g. as in (1)-(4), they assume a cis conformation, but this is not the case for (6), the bromo isomer of (3), as shown in Fig. 5 (bottom right). In spite of this, none of this type of derivative displays inhibitory activity towards the MAO-B isoenzyme. When the geometries of the relative positions of rings D and E of the chromone residue with respect to rings A and B are compared, it can be seen that the effect of the 2/3 positional isomerism is to 'reflect' their relative positions while the effect of the cis/trans conformations is a 'twofold rotation' of the rings around the C amide -C chromone bond. Those particular differences in conformation may condition the ability for docking when pharmacological activities are considered.
Supramolecular features
Intermolecular hydrogen-bonding information is given in Table 2 to 5. All compounds have the same supramolecular structure in which the C2-H2Á Á ÁO4(x + 1, y, z) and C316-H316Á Á ÁO3(x À 1, y, z) form R 2 2 (13) ring structures, which are propagated along the a-axis direction by unit translation. Fig. 6 shows the Cl compound, (3), as an example. There is -stacking in each compound, involving inversion-related molecules in all compounds, Table 6 .
Synthesis and crystallization
The title compounds were obtained by synthetic strategies described elsewhere (Cagide et al., 2011) . Chromone-3-carboxamides were synthesized using chromone-3-carboxylic acid as starting material which, after in situ activation with phosphorus ( Anti-rotamer conformations around the C-N rotamer for the 3-carboxamides (top) and for the 2-carboxamide isomers (bottom), showing the relative positions of the C3 arom -C2 arom bond of the chromone ring with respect to the carboxylic group of the amide: cis (right) or trans (left) geometries.
Figure 6
The distorted ladder formed by linked R 2 2 (13) rings in compound (3). The chain runs parallel to the a axis. Hydrogen bonds are indicated by blue dashed lines. Hydrogen atoms not involved in the hydrogen bonding have been omitted for clarity. A similar structure is found for compound (1) and all the halo-substituted compounds. [Symmetry codes: Table 6 -stacking (Å , ).
Cg1, Cg2, Cg3 and Cg7 [compound (6)] are the centroids of the rings containing atoms O1, C5, C311 and C211 [compound (6)], respectively. In contacts indicated *, the planes involved are inclined to each other, the perpendicular distance between the planes is an average value and the angle between the planes is given in place of a slippage. Only interplanar interactions with CgÁ Á ÁCg distances 4.0 Å and with angles between the planes of <10 are included. (9) react with the different haloanilines. Recrystallization from dichloromethane afforded colourless plates whose dimensions are given in Table 7 .
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 7 . Amino H atoms were located in difference Fourier maps and were refined isotropically. All other H atoms were treated as riding atoms with C-H(aromatic) = 0.95 Å , U iso = 1.2Ueq(C).
Compounds (1) and (2), reduced cell: [a = 6.6325 (12), b = 0.0577 (12), c = 14.671 (3) Å , = 76.464 (7), = 89.714 (6), = 74.411 (7) , V = 641.9 (2) Å 3 ], have different reduced cells in which the x and z coordinates are comparable and the y coordinate of (2) is close to 1 À y of (1). For ease of comparison of the structures of (1) and (2), the refinement reported here was carried out for the non-reduced cell of (2) in which the and angles were given the supplementary values of those of the reduced unit cell. The coordinates of (1) were used as starting values and the transformation matrix for the reduced to non-reduced cell was 1 0 0 0 1 0 0 0 1. This gave the same final refinement values as those for the refinement with the reduced cell. Compounds (1) and (2) (3) 6.6505 (5), 9.3580 (7), 11.0060 (8) 6.6750 (5), 9.4166 (7), 11.2673 (8) , , ( ) 101.957 (7), 90.047 (6), 106.657 (7) 103.536 (7), 89.714 (6), 105.589 (7) 100.280 (6), 90.461 (6), 100.884 (6) 100.974 (6) For all compounds, data collection: CrystalClear-SM Expert (Rigaku, 2012 ); cell refinement: CrystalClear-SM Expert (Rigaku, 2012) ; data reduction: CrystalClear-SM Expert (Rigaku, 2012 ); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) , PLATON (Spek, 2009) (Sheldrick, 2008) and PLATON (Spek, 2009 ).
(
1) N-(4-Fluorophenyl)-4-oxo-4H-chromene-3-carboxamide
Crystal data 
Special details
114.4 (2) C314-C313-H313 120.0 C8A-C4A-C5 118.5 (2) C312-C313-H313 120.0 C8A-C4A-C4 120.4 (2) C313-C314-C315 121.2 (2) C5-C4A-C4 121.1 (2) C313-C314-Cl14 119.82 (18) C6-C5-C4A 120.3 (3) C315-C314-Cl14 119.0 (2) C6-C5-H5 119.9 C316-C315-C314 119.1 (2) C4A-C5-H5 119.9 C316-C315-H315 120.4 C5-C6-C7 119.9 (2) C314-C315-H315 120.4
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Acta Cryst. (2015) . E71, 88-93 C5-C6-H6 120.1 C315-C316-C311 120.7 (2) C7-C6-H6 120.1 C315-C316-H316 119.6 C8-C7-C6 121.1 (2) C311-C316-H316 119.6 C8-C7-H7 119.5 O3-C31-N3 124.6 (2) C6-C7-H7 119.5 Geometric parameters (Å, º) 
